腫瘍に関連する中性粒子は,PSMA1- NF-κB- HIF- 1αシグナリング軸を通して中性粒子のトラップ分泌を媒介することによって前立腺がんの進行を促進します.
PubMedで要約を見る
まとめ
この要約は機械生成です。前立腺がんの患者は 中性粒子が増加しており 予後が悪いことを示す重要な指標です 新しい6遺伝子モデルと中性粒子の細胞外トラップ (NET) は前立腺がんの結果を予測するための新しい洞察を提供します.
科学分野
- 腫瘍学
- 免疫学
- バイオ情報学
背景
- 前立腺がん (PCa) は,世界中の男性にとって重大な健康上の脅威です.
- PSA検査のような現在の予測方法は 特殊性がないため 予測ツールが改善される必要があります
- PCaの予後を予測する効果的な臨床方法は,現在限られている.
研究 の 目的
- 前立腺がんの予後を予測する 新しいバイオマーカーを特定する
- PCaのための機械学習ベースの予測モデルを開発する.
- PCaの進行における中性粒子の役割と中性粒子の細胞外トラップ (NETs) を解明する.
主な方法
- クリニカルPCa患者のデータを遡及分析した.
- 予測モデル開発のためのLASSO回帰と機械学習
- 腫瘍微環境 (TME) とNETを分析するための解凍アルゴリズム,単細胞シーケンシング,およびオルガノイドモデル.
主要な成果
- PCa患者は,良性前立腺増殖と比較して,中性粒子のレベルが上昇し,合併症のリスクが高くなります.
- 6遺伝子の予後モデルでは 患者を高リスクと低リスクのグループに分けました
- 高リスクのPCa患者は,PSMA1- NF- kB- HIF- 1α軸経由でNET形成に関連したTME中性粒子の増加を示した.
結論
- 中性粒子の関連シグネチャー,特にNETは,PCaの予後を理解し予測するために不可欠です.
- 開発された予後モデルと特定された分子経路は,PCa管理の改善の可能性を提供します.
- NET形成をターゲットにすることは 前立腺がんの新たな治療戦略である可能性があります.
関連する概念動画
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

